Topic: Monoclonal Antibodies

The Human Metapneumovirus (HMPV) is spreading rapidly across the United States, with symptoms nearly identical to the common cold but no available vaccine. CDC data shows HMPV cases peaking in April, with Northern California seeing high concentrations in wastewater samples, prompting research into new monoclonal antibody treatments.

The CDC and FDA have approved new Pfizer vaccines and monoclonal antibody treatments for RSV, targeting pregnant women and "neonates" (newborns). Media coverage emphasizes a 57% reduction in hospitalization risk for infants. The marketing of these treatments is criticized for treating seasonal illnesses as pharmaceutical sales opportunities.

Dr. Deborah Birx appeared on ABC to discuss the predictable nature of COVID-19 summer waves and the need for seasonal boosters. Birx suggests that mRNA technology should be used to tailor vaccines for specific variants like BA.2.86 by January. The hosts critique her claims regarding the severity of COVID-19 compared to the flu and her dismissal of monoclonal antibodies in favor of antivirals like Remdesivir.

The discussion shifts to COVID-19 therapeutics, with the hosts noting that monoclonal antibodies are no longer available, leaving Pfizer's Paxlovid as the primary recommended treatment. They contrast this with alternative treatments like Ivermectin and Hydroxychloroquine. Adam Curry introduces the term "Balconazis" (Balcony Nazis), a phrase used in Spain to describe citizens who shouted at others to stay off the streets during pandemic lockdowns.

Dr. Robert Malone explained that the U.S. government views mRNA technology as a critical platform for rapid response to engineered pathogens and biowarfare. Malone noted that while monoclonal antibodies were previously preferred, they proved too "kludgey" for population-level deployment. The hosts debate whether Malone himself is an "op," given his open discussion of CIA strategic interests and his sudden prominence in alternative media.

The XBB.1.5 COVID-19 variant, nicknamed "Kraken" by an evolutionary biologist on Twitter, is spreading rapidly across the U.S. and New York. Health officials state the variant is highly contagious and capable of evading immunity from prior infections and monoclonal antibody treatments. In the UK, MP Andrew Bridgen was stripped of the Conservative Party whip after raising concerns about the safety and efficacy of the vaccines.

Donald Trump is increasingly being blamed for the failure of COVID-19 vaccines as public sentiment shifts. Media reports highlight First Lady Jill Biden experiencing a "rebound" case of COVID-19 after taking Paxlovid, mirroring a similar experience by President Joe Biden. Discussion includes Dan Bongino's reported regret over receiving multiple boosters after suffering a severe infection.

New ICD-10 billing codes have been established for COVID-19 treatments, including specific codes for booster doses administered into muscle or subcutaneous tissue. In Germany, a man was reportedly caught getting 90 COVID-19 vaccinations to sell the resulting legitimate vaccine cards to others. The discussion highlights the financial incentives for medical administrators to promote specific procedures.

A dark parody song titled "Suck the Plasma" mocks the use of monoclonal antibodies and convalescent plasma. The discussion defends hydroxychloroquine as a safe, long-standing drug that became unfairly politicized. A scathing musical critique of Dr. Anthony Fauci follows, alleging he is a "pathological liar" with ties to Big Pharma and a history of failing to cure HIV.

White House Press Secretary Jen Psaki warned that federal programs for COVID-19 testing, monoclonal antibodies, and antiviral treatments will be scaled back if Congress does not provide $22.5 billion in emergency funding. The administration claims that the lack of funding will leave the U.S. unprepared for future variants. Critics view this as a political setup to blame Republicans for any future resurgence of the virus after funding was stripped from a recent spending bill.

The FDA authorizes a new monoclonal antibody treatment from Eli Lilly specifically designed to fight the Omicron variant. This follows the removal of previous treatments from the market that were found ineffective against the new strain.

The FDA abruptly revoked the emergency use authorization for certain monoclonal antibody treatments, claiming they are ineffective against the Omicron variant. This decision resulted in the immediate cancellation of appointments for patients already scheduled for the treatment. Critics argue the move removes a vital tool for early intervention and leaves patients with fewer options.

The Biden administration is reportedly rationing monoclonal antibody treatments, with some states like New York prioritizing "black and brown people" due to disproportionate impact. Critics argue this policy is racially discriminatory. A healthcare worker suggested that a more equitable approach would be providing extra Vitamin D to those with more melanin, as they are more prone to deficiency.

HHS has paused the distribution of monoclonal antibody treatments nationally, claiming they are ineffective against Omicron. Medical professionals suggest this move is intended to "clear the deck" for Pfizer’s new oral antiviral pill, Paxlovid, which recently received emergency use authorization.

The FDA authorized a COVID-19 pill from Merck, though it is only recommended when Pfizer's more effective treatment is unavailable. Merck has faced criticism for not pursuing Ivermectin as a COVID treatment, despite a Japanese university offering to conduct tests on the drug.

Data shows a linear correlation between a high Body Mass Index (BMI) and the probability of developing severe COVID-19 symptoms. Meanwhile, podcast host Joe Rogan confirmed he did not receive the vaccine after a scheduled appointment was cancelled due to the Johnson & Johnson blood clot pause. Rogan credited his recovery from the virus to a regimen including monoclonal antibodies and ivermectin.

The Biden administration has begun "metering" the distribution of Regeneron monoclonal antibody treatments to states like Texas and Alabama. Officials in Montgomery County, Texas, expressed outrage, claiming the federal government is intentionally slowing down access to proven life-saving treatments for political reasons.

The American Board of Pediatrics issued a statement threatening to revoke the licenses of physicians who disseminate what they deem to be COVID-19 misinformation. Simultaneously, reports from Alex Berenson indicate that the federal government is restricting the supply of monoclonal antibody treatments to southern states like Florida and Texas. This is viewed as a punitive measure against states that have resisted federal vaccine mandates.

Mainstream media outlets have intensified efforts to discredit Ivermectin, often labeling it as "horse paste" following Joe Rogan's public use of the drug. A segment from KHOU in Houston argued that while the drug showed promise in petri dishes, it failed in clinical trials, while simultaneously promoting expensive monoclonal antibody treatments.

Joe Rogan announces he tested positive for COVID-19 after a comedy show and utilized a "kitchen sink" of treatments, including ivermectin and monoclonal antibodies. NPR and other media outlets criticize Rogan for using ivermectin, frequently labeling it a "horse dewormer" and citing FDA warnings against animal-grade versions of the drug. The coverage is characterized as a coordinated effort to discredit Rogan's recovery method.